Although NU7026 suppressed DNA-PKcs levels markedly (Fig. 6E), it only reversed pulmonary vascular remodeling, without changes of pulmonary hypertension and right ventricular hypertrophy. The gene discussed is PRKDC; the disease is pulmonary arterial hypertension.